Filing Details
- Accession Number:
- 0001209191-22-014447
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-01 21:18:09
- Reporting Period:
- 2022-02-25
- Accepted Time:
- 2022-03-01 21:18:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1020214 | Cerus Corp | CERS | Surgical & Medical Instruments & Apparatus (3841) | 680262011 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1377258 | Mariner William Greenman | C/O Cerus Corporation 1220 Concord Ave Suite 600 Concord CA 94520 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-02-25 | 380,000 | $3.75 | 1,902,281 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-02-25 | 215,263 | $5.69 | 1,687,018 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2022-02-25 | 93,000 | $5.73 | 1,594,018 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-03-01 | 217,500 | $0.00 | 1,811,518 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Option (Right to Buy) | Disposition | 2022-02-25 | 380,000 | $0.00 | 380,000 | $3.75 |
| Common Stock | Option (Right to Buy) | Acquisiton | 2022-03-01 | 435,000 | $0.00 | 435,000 | $5.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-02-28 | No | 4 | M | Direct | |
| 435,000 | 2032-02-28 | No | 4 | A | Direct |
Footnotes
- Includes 1,445 and 2,164 shares purchased under Issuer's Employee Stock Purchase Plan on 08/31/21 and 02/28/22.
- Represents shares sold to cover the exercise price, the statutory tax withholding obligations and corresponding brokerage fee in connection with the exercise of the option listed in Table II prior to expiration.
- The reported price in column 4 is a weighted average price ranging from $5.56 to $5.77 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- The reported price in column 4 is a weighted average price ranging from $5.665 to $5.79 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth.
- Represents the number of shares underlying RSUs. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vests in three equal annual installments beginning on March 12, 2023, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
- One eighth (1/8) of the shares subject to the Option shall vest six (6) months after the transaction date and one forty-eighth (1/48th) of the shares subject to the Option shall vest monthly thereafter.
- Not applicable.
- One forth (1/4) of the shares subject to the Option shall vest on the first anniversary of the grant date, and one forty-eighth (1/48th) of the shares subject to the Option vest monthly thereafter.
Billionaire Hedge Funds
